Surgical procedures for benign prostatic hyperplasia: A nationwide survey in Japan

被引:27
|
作者
Masumori, Naoya [1 ]
Kamoto, Toshiyuki [2 ]
Seki, Narihito [3 ]
Homma, Yukio [4 ]
机构
[1] Sapporo Med Univ, Sch Med, Dept Urol, Sapporo, Hokkaido 0608543, Japan
[2] Miyazaki Univ, Fac Med, Dept Urol, Miyazaki, Japan
[3] Kyushu Univ, Dept Urol, Fukuoka 812, Japan
[4] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan
关键词
benign prostatic hyperplasia; nationwide survey; surgery;
D O I
10.1111/j.1442-2042.2010.02687.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We investigated the trend in surgical procedures for benign prostatic hyperplasia (BPH) during the past 10 years in Japan. A questionnaire inquiring about the number of operations and surgical procedures for BPH in 1999, 2004 and 2009 was sent to 1824 institutes belonging to the Japanese Urological Association and/or the Japanese Clinical Urologists Association. Responses were obtained from 767 institutes (42.1%). The number of operations showed a gradual increase during the 10 years (n = 17 221 in 1999, 18 772 in 2004, 20 413 in 2009). Transurethral resection of the prostate, including transurethral resection in saline, was consistently the most common procedure (72.5% to 79.2%). Holmium laser enucleation of the prostate and transurethral enucleation with a bipolar system have dramatically increased, becoming the second most common in 2009 (n = 3416), although enucleation by open prostatectomy was still a viable option in 2009 (n = 555). Photoselective vaporization of the prostate was the third most common method in 2009 (n = 572). Coagulation and thermotherapy have become uncommon (n = 2039 in 1999, 217 in 2009), whereas incision and stenting were unchanged during the period. Thus, surgical procedures for BPH have been increasing in Japan during the past decade. Transurethral resection remains the standard, whereas enucleation and vaporization have been increasing.
引用
收藏
页码:166 / 170
页数:5
相关论文
共 50 条
  • [41] HoLEP: the new gold standard for surgical treatment of benign prostatic hyperplasia
    Shvero, Asaf
    Calio, Brian
    Humphreys, Mitchell R.
    Das, Akhil K.
    CANADIAN JOURNAL OF UROLOGY, 2021, 28 : 6 - 10
  • [42] Epidemiology of benign prostatic hyperplasia
    Robert, G.
    De La Taille, A.
    Descazeaud, A.
    PROGRES EN UROLOGIE, 2018, 28 (15): : 803 - 812
  • [43] Sexual Side Effects of Medical and Surgical Benign Prostatic Hyperplasia Treatments
    Welliver, Charles
    Essa, Ahmed
    UROLOGIC CLINICS OF NORTH AMERICA, 2016, 43 (03) : 393 - +
  • [44] Benign prostatic hyperplasia and heredity
    Cetinkaya, Mesut
    Oztekin, Cetin Volkan
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2011, 10 (04): : 20 - 22
  • [45] Testosterone and Benign Prostatic Hyperplasia
    Rastrelli, Giulia
    Vignozzi, Linda
    Corona, Giovanni
    Maggi, Mario
    SEXUAL MEDICINE REVIEWS, 2019, 7 (02) : 259 - 271
  • [46] Benign prostatic hyperplasia in the dog
    Cunto, Marco
    Ballotta, Giulia
    Zambelli, Daniele
    ANIMAL REPRODUCTION SCIENCE, 2022, 247
  • [47] Testosterone and benign prostatic hyperplasia
    Jarvis, Thomas R.
    Chughtai, Bilal
    Kaplan, Steven A.
    ASIAN JOURNAL OF ANDROLOGY, 2015, 17 (02) : 212 - 216
  • [48] Nutrition and benign prostatic hyperplasia
    Espinosa, Geovanni
    CURRENT OPINION IN UROLOGY, 2013, 23 (01) : 38 - 41
  • [49] Androgens and benign prostatic hyperplasia
    Mirone, V
    Fusco, F
    Verze, P
    Schulman, C
    Debruyne, F
    Imbimbo, C
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (04) : 410 - 417
  • [50] THERMOTHERAPY IN BENIGN PROSTATIC HYPERPLASIA
    HOFNER, K
    KRAH, H
    TAN, HK
    KUCZYK, M
    JONAS, U
    UROLOGE-AUSGABE A, 1995, 34 (01): : 16 - 24